RecruitingNCT03137355

The International Registry for Leigh Syndrome


Sponsor

The University of Texas Health Science Center, Houston

Enrollment

200 participants

Start Date

Jun 17, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to develop a database containing clinical and laboratory information for patients with Leigh syndrome. The goal is to provide a greater understanding of Leigh syndrome allowing further characterization of this disease.


Eligibility

Min Age: 0 DaysMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

Leigh syndrome is a severe, progressive neurological disorder that typically appears in infancy or early childhood and is caused by mutations in genes involved in energy production in cells. This international registry collects detailed clinical data from patients with Leigh syndrome to improve understanding of the disease and support future research and treatment development. You may be eligible if: - You have been diagnosed with Leigh syndrome You may NOT be eligible if: - You do not have a diagnosis of Leigh syndrome Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

The University of Texas Health Science Center at Houston

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03137355


Related Trials